Two Sigma Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-122,400
Closed -$11.2M 4233
2021
Q4
$11.2M Sell
122,400
-15,100
-11% -$1.8M 0.02% 723
2021
Q3
$17.4M Sell
137,500
-63,000
-31% -$9.17M 0.04% 522
2021
Q2
$33.3M Buy
200,500
+95,700
+91% +$15.5M 0.08% 315
2021
Q1
$19M Buy
104,800
+16,500
+19% +$3.83M 0.05% 457
2020
Q4
$17.7M Sell
88,300
-33,500
-28% -$6.81M 0.05% 413
2020
Q3
$26.7M Buy
121,800
+71,600
+143% +$15.2M 0.09% 223
2020
Q2
$9.58M Buy
50,200
+36,700
+272% +$6.43M 0.05% 405
2020
Q1
$2.09M Sell
13,500
-9,300
-41% -$1.08M 0.02% 940
2019
Q4
$1.91M Buy
22,800
+17,800
+356% +$1.35M 0.01% 1624
2019
Q3
$339K Buy
+5,000
New +$329K ﹤0.01% 2876
2019
Q1
Sell
-6,000
Closed -$297K 3459
2018
Q4
$297K Buy
6,000
+3,000
+100% +$184K ﹤0.01% 2452
2018
Q3
$259K Buy
+3,000
New +$214K ﹤0.01% 2858

Other funds holding TDOC

Two Sigma Investments's TDOC Position: Q1 2026 in Review

Two Sigma Investments reduced its Teladoc Health (TDOC) stake by 79% in Q1 2026, selling an estimated $3.02M and leaving 138,998 shares worth $758K. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

Two Sigma Investments first reported a position in TDOC in Q1 2016 and has held it in 21 quarters since. The position peaked at $83.7M in Q2 2022. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Two Sigma Investments held 138,998 shares of Teladoc Health worth $758K as of Q1 2026.
  • Two Sigma Investments sold 538,557 Teladoc Health shares in Q1 2026, an estimated $3.02M.
  • Teladoc Health made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3454 holding.
  • Two Sigma Investments first reported a position in Teladoc Health in Q1 2016 and has held it in 21 quarters since.
  • Two Sigma Investments's Teladoc Health position peaked at $83.7M in Q2 2022.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.